CytoMed Therapeutics Ltd (GDTC)
2.11
-0.02
(-0.94%)
USD |
NASDAQ |
May 17, 16:00
2.11
0.00 (0.00%)
After-Hours: 20:00
CytoMed Therapeutics Cash from Operations (TTM): -2.555M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -2.555M |
June 30, 2023 | -2.178M |
December 31, 2022 | -1.011M |
Date | Value |
---|---|
June 30, 2022 | -1.148M |
December 31, 2021 | -1.271M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-2.555M
Minimum
Dec 2023
-1.011M
Maximum
Dec 2022
-1.632M
Average
-1.271M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
Haw Par Corp Ltd | -- |
WAVE Life Sciences Ltd | -138.38M |
ASLAN Pharmaceuticals Ltd | -- |
EUDA Health Holdings Ltd | -- |
Mobile-health Network Solutions | -2.249M |